1312 — Kontafarma China Holdings Cashflow Statement
0.000.00%
- HK$145.30m
- HK$334.74m
- HK$897.52m
Annual cashflow statement for Kontafarma China Holdings, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | — |
Source: | ARS | ARS | ARS | ARS | |
Standards: | HKAS | HKAS | HKAS | HKAS | — |
Status: | Final | Final | Final | Final | fx Preliminary |
Net Income/Starting Line | -0.297 | -0.326 | -118 | -43.9 | — |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 188 | -54.1 | 121 | -20.7 | — |
Discontinued Operations | |||||
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -158 | -62 | -136 | -5.43 | — |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 207 | 75.1 | -2.17 | 37.1 | — |
Capital Expenditures | -166 | -124 | -51.7 | -24.2 | — |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -39.9 | 148 | 173 | 168 | — |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -206 | 23.2 | 122 | 144 | — |
Financing Cash Flow Items | -112 | -101 | -135 | -33 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 19.1 | -99.8 | -137 | -199 | — |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 17.5 | 2.14 | -45.4 | -44.9 | — |